0001567619-21-022297.txt : 20211217 0001567619-21-022297.hdr.sgml : 20211217 20211217190334 ACCESSION NUMBER: 0001567619-21-022297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211210 FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 211503182 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2021-12-10 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2021-12-10 5 G 0 700 0 D 303689 D Common Stock 2021-12-15 4 M 0 6000 37.46 A 309689 D Common Stock 2021-12-15 4 S 0 6000 82.71 D 303689 D Common Stock 2021-12-16 4 M 0 6000 37.46 A 309689 D Common Stock 2021-12-16 4 S 0 6000 84.68 D 303689 D Common Stock 247533 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (Right to buy Common Stock) 37.46 2021-12-15 4 M 0 6000 0 D 2012-11-08 2022-05-07 Common Stock 6000 131000 D Stock Option (Right to buy Common Stock) 37.46 2021-12-16 4 M 0 6000 0 D 2012-11-08 2022-05-07 Common Stock 6000 125000 D On December 10, 2021 the reporting person gifted 700 shares to an educational institution. Trade made pursuant to a 10b5-1 plan executed on October 13, 2021. Reflects the number of options outstanding after the transactions from this specific stock option grant. /s/ Eric Fleekop, Attorney-in-Fact 2021-12-17